Publisher's Synopsis
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser - or aspire to be one - then you need to build and analyze forecasts and valuations of R&D-stage drugs. This book is for you.
The Pharmagellan Guide to Biotech Forecasting and Valuation
First edition
Paperback (06 Jan 2017)
Save $5.46
-
RRP $101.44 - $95.98
Includes delivery to the United States
10+ copies available online - Usually dispatched within 7 days
Check stock
Book information
| ISBN: | 9780998407500 |
| Publisher: | Pharmagellan |
| Imprint: | Pharmagellan |
| Pub date: | 06 Jan 2017 |
| Edition: | First edition |
| DEWEY: | 338.476606 |
| DEWEY edition: | 23 |
| Language: | English |
| Number of pages: | xi, 124 |
| Weight: | 222g |
| Height: | 151mm |
| Width: | 228mm |
| Spine width: | 14mm |
